HUP0300778A2 - Tiazolidindion-származék tartarátsója - Google Patents

Tiazolidindion-származék tartarátsója

Info

Publication number
HUP0300778A2
HUP0300778A2 HU0300778A HUP0300778A HUP0300778A2 HU P0300778 A2 HUP0300778 A2 HU P0300778A2 HU 0300778 A HU0300778 A HU 0300778A HU P0300778 A HUP0300778 A HU P0300778A HU P0300778 A2 HUP0300778 A2 HU P0300778A2
Authority
HU
Hungary
Prior art keywords
tartrate
sal
thiazolidinedione derivative
active pharmaceutical
pharmaceutical ingredient
Prior art date
Application number
HU0300778A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0300778A2 publication Critical patent/HUP0300778A2/hu
Publication of HUP0300778A3 publication Critical patent/HUP0300778A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)

Abstract

A találmány az 5-[4-{2-[N-metil-lU-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-DL-tartarátra és szolvátjaira mint újgyógyszerhatóanyagra, a gyógyszerhatóanyag előállítási eljárására, agyógyszerhatóanyagot tartalmazó gyógyszerkészítményekre, valamint agyógyszerhatóanyag gyógyászati alkalmazására vonatkozik. Ó
HU0300778A 2000-08-04 2001-08-03 Tartrate sal of thiazolidinedione derivative HUP0300778A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (2)

Publication Number Publication Date
HUP0300778A2 true HUP0300778A2 (hu) 2003-11-28
HUP0300778A3 HUP0300778A3 (en) 2005-04-28

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300778A HUP0300778A3 (en) 2000-08-04 2001-08-03 Tartrate sal of thiazolidinedione derivative

Country Status (37)

Country Link
US (1) US20040014790A1 (hu)
EP (1) EP1305311B1 (hu)
JP (1) JP2004505970A (hu)
KR (1) KR100755174B1 (hu)
CN (1) CN1455778A (hu)
AP (1) AP1785A (hu)
AT (1) ATE384059T1 (hu)
AU (1) AU2001276506A1 (hu)
BG (1) BG107604A (hu)
BR (1) BR0112982A (hu)
CA (1) CA2417827A1 (hu)
CY (1) CY1107252T1 (hu)
CZ (1) CZ2003313A3 (hu)
DE (1) DE60132461T2 (hu)
DK (1) DK1305311T3 (hu)
DZ (1) DZ3418A1 (hu)
EA (1) EA005408B1 (hu)
EC (1) ECSP034467A (hu)
ES (1) ES2296772T3 (hu)
GB (1) GB0019224D0 (hu)
HK (1) HK1057358A1 (hu)
HR (1) HRP20030068B1 (hu)
HU (1) HUP0300778A3 (hu)
IL (2) IL154275A0 (hu)
MA (1) MA25832A1 (hu)
MX (1) MXPA03001085A (hu)
NO (1) NO324596B1 (hu)
NZ (1) NZ524030A (hu)
OA (1) OA12354A (hu)
PL (1) PL360662A1 (hu)
PT (1) PT1305311E (hu)
SI (1) SI1305311T1 (hu)
SK (1) SK1462003A3 (hu)
UA (1) UA76720C2 (hu)
WO (1) WO2002012232A1 (hu)
YU (1) YU14603A (hu)
ZA (1) ZA200300961B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN108348292B (zh) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 具有机械性导引的微针装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR100755174B1 (ko) 2007-09-03
AU2001276506A1 (en) 2002-02-18
JP2004505970A (ja) 2004-02-26
ZA200300961B (en) 2004-04-01
DE60132461T2 (de) 2008-12-24
NZ524030A (en) 2004-07-30
PL360662A1 (en) 2004-09-20
HUP0300778A3 (en) 2005-04-28
SK1462003A3 (en) 2004-06-08
EA005408B1 (ru) 2005-02-24
CY1107252T1 (el) 2012-11-21
WO2002012232A1 (en) 2002-02-14
PT1305311E (pt) 2008-04-07
CN1455778A (zh) 2003-11-12
CA2417827A1 (en) 2002-02-14
AP2003002736A0 (en) 2003-03-31
MA25832A1 (fr) 2003-07-01
YU14603A (sh) 2006-05-25
BR0112982A (pt) 2003-08-26
SI1305311T1 (sl) 2008-04-30
IL154275A (en) 2009-02-11
MXPA03001085A (es) 2003-05-27
EP1305311A1 (en) 2003-05-02
BG107604A (bg) 2003-09-30
US20040014790A1 (en) 2004-01-22
DK1305311T3 (da) 2008-05-19
ATE384059T1 (de) 2008-02-15
DE60132461D1 (de) 2008-03-06
EA200300230A1 (ru) 2003-06-26
AP1785A (en) 2007-10-04
HRP20030068A2 (en) 2005-02-28
KR20030022355A (ko) 2003-03-15
NO20030530D0 (no) 2003-02-03
EP1305311B1 (en) 2008-01-16
UA76720C2 (uk) 2006-09-15
CZ2003313A3 (cs) 2004-02-18
ECSP034467A (es) 2003-03-31
OA12354A (en) 2004-03-19
IL154275A0 (en) 2003-09-17
ES2296772T3 (es) 2008-05-01
NO324596B1 (no) 2007-11-26
DZ3418A1 (fr) 2002-02-14
GB0019224D0 (en) 2000-09-27
NO20030530L (no) 2003-02-03
HK1057358A1 (en) 2004-04-02
HRP20030068B1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
HUP0204122A2 (hu) Dioxo-tiazolidint és hetformint tartalmazó gyógyszerkészítmény és felhasználása
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
HUP0301512A2 (hu) Gyomor-bél csatornában fellépő kötőszöveti váz tumorok kezelése
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
HUP0401605A2 (hu) Szembetegségek kezelésére szolgáló integrin gátlók
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
HUP0300777A2 (hu) Tiazolidindion-származék tartarátsója
HUP0300778A2 (hu) Tiazolidindion-származék tartarátsója
CO5261595A1 (es) Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium
ATE400563T1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
HUP0300770A2 (hu) Tiazolidindion-származék tartarátsója
HUP0300938A2 (hu) Az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin hidrokloridsója
HUP0301137A2 (hu) Dioxo-tiazolidin-só diabetes mellitus kezelésére, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
HUP0300724A2 (hu) Tiazolidindion-származék tartarátsója
HUP0301199A2 (hu) Dioxo-tiazolidin-származék és antidiabetikumként történő alkalmazása
HUP0400776A2 (hu) N-(Metiletilaminokarbonil)-4-(3-metilfenilamino)-3-piridilszulfonamid és gyűrűs oligoszacharidok kompozíciói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0401285A2 (hu) 4-[Fenil-(4-piperidinilidén)-metil]-benzamid-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
MY141008A (en) Oral formulations of deoxypeganine and their uses
HUP0301188A2 (hu) 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin nátriumsók, eljárás az előállításukra, és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees